Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

The five key claims in Benchmark’s lawsuit against Uber founder Travis Kalanick are definitely gnarly

It’s a blockbuster. It may be an Uber-buster too.

Former Uber CEO Travis Kalanick
Former Uber CEO Travis Kalanick
Travis Kalanick
Money Sharma / Getty

The extraordinary lawsuit from Benchmark Capital against Travis Kalanick, the former CEO of Uber, its most valuable portfolio company, boils down to a series of ugly claims that Benchmark said shows Kalanick’s “gross mismanagement.”

Meanwhile, Kalanick called the lawsuit “completely without merit and riddled with lies and false allegations.”

In any case, here’s the crux of Benchmark’s lawsuit, which is pretty devastating to Kalanick and to Uber:

  • Board seats: “Kalanick fraudulently obtained control of three newly created seats on Uber’s Board by his material misstatements and fraudulent concealment from Benchmark of material information that would have led Benchmark to reject the creation of the seats.”
  • Waymo lawsuit: “The Waymo lawsuit presents significant legal, financial, and reputational risks to Uber — risks that could have been reduced or avoided if Kalanick had disclosed crucial facts about his own apparent knowledge at the time of the Otto acquisition.”
  • India rape case: “The alleged mishandling of the India rape victim’s medical records — which has since understandably received significant press coverage and criticism — was known to Kalanick at the time of the amendments to the Certificate of Incorporation and the Prior Voting Agreement, but not disclosed to Uber’s Board or Benchmark at the time.”
  • Sexual harassment: “The pervasive cultural issues explored in Covington’s investigation were known to and facilitated by Kalanick at the time of the amendments to the Certificate of Incorporation and the Prior Voting Agreement, but Kalanick did not disclose these matters to Uber’s Board or Benchmark at the time.”
  • Program to track regulators called “Greyball”: “Upon information and belief, Kalanick was aware of the Greyball program at the time of the amendments to the Certificate of Incorporation and the Prior Voting Agreement, but Kalanick did not disclose these matters to Uber’s Board or Benchmark at the time.”

You can read the entire lawsuit here to judge for yourself.


This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh